CN Stock MarketDetailed Quotes

301370 GKHT Medical Technology

Watchlist
  • 10.02
  • -0.18-1.76%
Trading Jul 26 10:25 CST
4.72BMarket Cap30.36P/E (TTM)

GKHT Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-3.00%1.71B
17.66%7.48B
17.74%5.76B
28.41%3.88B
14.98%1.77B
8.76%6.36B
-15.92%4.89B
-21.33%3.02B
-12.81%1.54B
20.27%5.85B
Operating revenue
-3.00%1.71B
17.66%7.48B
17.74%5.76B
28.41%3.88B
14.98%1.77B
8.76%6.36B
-15.92%4.89B
-21.33%3.02B
-12.81%1.54B
20.27%5.85B
Other operating revenue
----
12.92%36.81M
----
58.55%19.39M
----
-0.91%32.6M
----
-7.57%12.23M
--7.63M
-48.97%32.9M
Total operating cost
-1.49%1.68B
18.31%7.24B
18.28%5.57B
28.59%3.74B
15.48%1.71B
9.78%6.12B
4.71B
-21.81%2.91B
1.48B
21.06%5.58B
Operating cost
-1.36%1.53B
19.65%6.6B
18.80%5.07B
29.74%3.4B
16.13%1.56B
9.93%5.52B
--4.27B
-23.97%2.62B
--1.34B
21.73%5.02B
Operating tax surcharges
-7.72%4.44M
-1.10%19.25M
17.14%12.64M
19.06%8.93M
26.09%4.81M
1.39%19.47M
-19.69%10.79M
-10.01%7.5M
--3.82M
168.68%19.2M
Operating expense
1.05%85.26M
14.88%376.17M
19.83%282.77M
29.74%189.53M
22.83%84.37M
17.84%327.46M
--235.98M
10.12%146.08M
--68.69M
16.97%277.89M
Administration expense
19.31%36.3M
17.65%141.78M
30.90%121.91M
25.83%77.11M
0.64%30.42M
6.72%120.51M
--93.13M
10.53%61.28M
--30.23M
9.99%112.93M
Financial expense
-34.40%19.53M
-28.36%87.15M
-19.42%75.63M
-14.20%55.79M
-12.26%29.77M
-9.48%121.65M
--93.85M
-5.02%65.02M
--33.93M
7.03%134.38M
-Interest expense (Financial expense)
-36.30%17.89M
-26.10%88.18M
-18.19%73.43M
-14.48%53.26M
-12.57%28.09M
-7.48%119.32M
--89.76M
-1.80%62.28M
--32.13M
8.24%128.96M
-Interest Income (Financial expense)
10.37%-1.28M
-77.01%-5.62M
-102.19%-4.3M
-91.17%-2.48M
-135.79%-1.43M
-11.32%-3.18M
---2.13M
19.66%-1.3M
---605.06K
-16.80%-2.85M
Research and development
-17.72%2.46M
4.03%12.9M
-1.66%8.65M
1.33%5.68M
10.12%2.99M
17.57%12.4M
11.53%8.8M
6.55%5.6M
--2.72M
29.25%10.55M
Credit Impairment Loss
116.18%1.61M
126.01%10.51M
-4.48%-31.16M
-4.53%-23.16M
-2.31%-9.95M
-69.04%-40.41M
-48.62%-29.83M
-58.22%-22.15M
---9.73M
-27.70%-23.9M
Asset Impairment Loss
3.39%-6.82M
-54.93%-17.33M
-29.43%-10.64M
-162.85%-10.27M
-69.97%-7.06M
37.02%-11.19M
---8.22M
76.90%-3.91M
---4.15M
27.80%-17.76M
Other net revenue
69.96%-4.9M
93.69%-2.65M
-13.50%-35.14M
-35.58%-32.07M
-23.35%-16.31M
-47.58%-41.93M
-54.26%-30.96M
11.33%-23.66M
-13.22M
23.40%-28.41M
Invest income
----
---4.99M
----
----
----
--0
----
----
----
----
Asset deal income
-13,315.40%-164.18K
-184.06%-182.79K
-550.09%-127.9K
-90.80%2.6K
38.84%-1.22K
853.54%217.46K
--28.42K
--28.22K
---2K
---28.86K
Other revenue
-32.79%472.77K
-1.02%9.35M
-3.82%6.79M
-43.01%1.36M
6.36%703.44K
-28.91%9.44M
--7.06M
-43.94%2.38M
--661.4K
113.28%13.28M
Operating profit
-37.06%27.42M
21.33%239.07M
2.03%157.4M
20.66%105.34M
-3.80%43.56M
-19.02%197.04M
6.10%154.28M
-4.70%87.3M
1.02%45.29M
10.90%243.32M
Add:Non operating Income
1,656.19%15.81K
-98.49%5K
-98.48%4.78K
-98.57%4.25K
354.55%900
844.07%331.43K
16,478.02%314.98K
26,891.51%296.88K
--198
576.65%35.11K
Less:Non operating expense
-76.06%248.37K
91.13%2.99M
82.26%1.89M
223.62%1.12M
538.39%1.04M
3.05%1.57M
2.32%1.04M
-31.57%345.75K
--162.54K
-49.76%1.52M
Total profit
-36.08%27.18M
20.57%236.08M
1.28%155.51M
19.45%104.23M
-5.76%42.53M
-19.03%195.81M
6.35%153.55M
-4.23%87.25M
1.44%45.12M
11.76%241.84M
Less:Income tax cost
-65.84%4.7M
21.70%65.37M
31.34%54.33M
49.67%32.09M
18.89%13.75M
-13.36%53.71M
--41.37M
-9.98%21.44M
--11.57M
6.49%62M
Net profit
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
6.42%112.19M
-2.19%65.81M
-4.69%33.56M
13.71%179.84M
Net profit from continuing operation
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
--112.19M
-2.19%65.81M
--33.56M
13.71%179.84M
Less:Minority Profit
-310.16%-5.12M
-2.06%16.83M
-42.93%10.17M
-48.44%6.2M
-70.41%2.44M
-39.97%17.19M
--17.83M
8.08%12.03M
--8.23M
135.92%28.63M
Net profit of parent company owners
4.82%27.61M
23.19%153.88M
-3.55%91.01M
22.59%65.93M
4.01%26.34M
-17.39%124.91M
3.36%94.36M
-4.23%53.78M
-1.37%25.32M
3.55%151.21M
Earning per share
Basic earning per share
-14.29%0.06
16.13%0.36
-8.33%0.22
23.08%0.16
16.67%0.07
-18.42%0.31
--0.24
-7.14%0.13
--0.06
2.70%0.38
Diluted earning per share
-14.29%0.06
16.13%0.36
-8.33%0.22
23.08%0.16
--0.07
--0.31
--0.24
--0.13
----
----
Other composite income
Total composite income
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
112.19M
-2.19%65.81M
33.56M
13.71%179.84M
Total composite income of parent company owners
4.82%27.61M
23.19%153.88M
-3.55%91.01M
22.59%65.93M
4.01%26.34M
-17.39%124.91M
--94.36M
-4.23%53.78M
--25.32M
3.55%151.21M
Total composite income of minority owners
-310.16%-5.12M
-2.06%16.83M
-42.93%10.17M
-48.44%6.2M
-70.41%2.44M
-39.97%17.19M
--17.83M
8.08%12.03M
--8.23M
135.92%28.63M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -3.00%1.71B17.66%7.48B17.74%5.76B28.41%3.88B14.98%1.77B8.76%6.36B-15.92%4.89B-21.33%3.02B-12.81%1.54B20.27%5.85B
Operating revenue -3.00%1.71B17.66%7.48B17.74%5.76B28.41%3.88B14.98%1.77B8.76%6.36B-15.92%4.89B-21.33%3.02B-12.81%1.54B20.27%5.85B
Other operating revenue ----12.92%36.81M----58.55%19.39M-----0.91%32.6M-----7.57%12.23M--7.63M-48.97%32.9M
Total operating cost -1.49%1.68B18.31%7.24B18.28%5.57B28.59%3.74B15.48%1.71B9.78%6.12B4.71B-21.81%2.91B1.48B21.06%5.58B
Operating cost -1.36%1.53B19.65%6.6B18.80%5.07B29.74%3.4B16.13%1.56B9.93%5.52B--4.27B-23.97%2.62B--1.34B21.73%5.02B
Operating tax surcharges -7.72%4.44M-1.10%19.25M17.14%12.64M19.06%8.93M26.09%4.81M1.39%19.47M-19.69%10.79M-10.01%7.5M--3.82M168.68%19.2M
Operating expense 1.05%85.26M14.88%376.17M19.83%282.77M29.74%189.53M22.83%84.37M17.84%327.46M--235.98M10.12%146.08M--68.69M16.97%277.89M
Administration expense 19.31%36.3M17.65%141.78M30.90%121.91M25.83%77.11M0.64%30.42M6.72%120.51M--93.13M10.53%61.28M--30.23M9.99%112.93M
Financial expense -34.40%19.53M-28.36%87.15M-19.42%75.63M-14.20%55.79M-12.26%29.77M-9.48%121.65M--93.85M-5.02%65.02M--33.93M7.03%134.38M
-Interest expense (Financial expense) -36.30%17.89M-26.10%88.18M-18.19%73.43M-14.48%53.26M-12.57%28.09M-7.48%119.32M--89.76M-1.80%62.28M--32.13M8.24%128.96M
-Interest Income (Financial expense) 10.37%-1.28M-77.01%-5.62M-102.19%-4.3M-91.17%-2.48M-135.79%-1.43M-11.32%-3.18M---2.13M19.66%-1.3M---605.06K-16.80%-2.85M
Research and development -17.72%2.46M4.03%12.9M-1.66%8.65M1.33%5.68M10.12%2.99M17.57%12.4M11.53%8.8M6.55%5.6M--2.72M29.25%10.55M
Credit Impairment Loss 116.18%1.61M126.01%10.51M-4.48%-31.16M-4.53%-23.16M-2.31%-9.95M-69.04%-40.41M-48.62%-29.83M-58.22%-22.15M---9.73M-27.70%-23.9M
Asset Impairment Loss 3.39%-6.82M-54.93%-17.33M-29.43%-10.64M-162.85%-10.27M-69.97%-7.06M37.02%-11.19M---8.22M76.90%-3.91M---4.15M27.80%-17.76M
Other net revenue 69.96%-4.9M93.69%-2.65M-13.50%-35.14M-35.58%-32.07M-23.35%-16.31M-47.58%-41.93M-54.26%-30.96M11.33%-23.66M-13.22M23.40%-28.41M
Invest income -------4.99M--------------0----------------
Asset deal income -13,315.40%-164.18K-184.06%-182.79K-550.09%-127.9K-90.80%2.6K38.84%-1.22K853.54%217.46K--28.42K--28.22K---2K---28.86K
Other revenue -32.79%472.77K-1.02%9.35M-3.82%6.79M-43.01%1.36M6.36%703.44K-28.91%9.44M--7.06M-43.94%2.38M--661.4K113.28%13.28M
Operating profit -37.06%27.42M21.33%239.07M2.03%157.4M20.66%105.34M-3.80%43.56M-19.02%197.04M6.10%154.28M-4.70%87.3M1.02%45.29M10.90%243.32M
Add:Non operating Income 1,656.19%15.81K-98.49%5K-98.48%4.78K-98.57%4.25K354.55%900844.07%331.43K16,478.02%314.98K26,891.51%296.88K--198576.65%35.11K
Less:Non operating expense -76.06%248.37K91.13%2.99M82.26%1.89M223.62%1.12M538.39%1.04M3.05%1.57M2.32%1.04M-31.57%345.75K--162.54K-49.76%1.52M
Total profit -36.08%27.18M20.57%236.08M1.28%155.51M19.45%104.23M-5.76%42.53M-19.03%195.81M6.35%153.55M-4.23%87.25M1.44%45.12M11.76%241.84M
Less:Income tax cost -65.84%4.7M21.70%65.37M31.34%54.33M49.67%32.09M18.89%13.75M-13.36%53.71M--41.37M-9.98%21.44M--11.57M6.49%62M
Net profit -21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M6.42%112.19M-2.19%65.81M-4.69%33.56M13.71%179.84M
Net profit from continuing operation -21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M--112.19M-2.19%65.81M--33.56M13.71%179.84M
Less:Minority Profit -310.16%-5.12M-2.06%16.83M-42.93%10.17M-48.44%6.2M-70.41%2.44M-39.97%17.19M--17.83M8.08%12.03M--8.23M135.92%28.63M
Net profit of parent company owners 4.82%27.61M23.19%153.88M-3.55%91.01M22.59%65.93M4.01%26.34M-17.39%124.91M3.36%94.36M-4.23%53.78M-1.37%25.32M3.55%151.21M
Earning per share
Basic earning per share -14.29%0.0616.13%0.36-8.33%0.2223.08%0.1616.67%0.07-18.42%0.31--0.24-7.14%0.13--0.062.70%0.38
Diluted earning per share -14.29%0.0616.13%0.36-8.33%0.2223.08%0.16--0.07--0.31--0.24--0.13--------
Other composite income
Total composite income -21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M112.19M-2.19%65.81M33.56M13.71%179.84M
Total composite income of parent company owners 4.82%27.61M23.19%153.88M-3.55%91.01M22.59%65.93M4.01%26.34M-17.39%124.91M--94.36M-4.23%53.78M--25.32M3.55%151.21M
Total composite income of minority owners -310.16%-5.12M-2.06%16.83M-42.93%10.17M-48.44%6.2M-70.41%2.44M-39.97%17.19M--17.83M8.08%12.03M--8.23M135.92%28.63M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg